Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pain

We Want You: Your Role in the CPT Valuation Process

Carina Stanton  |  October 23, 2023

Accurate reimbursement for rheumatology services ensures rheumatologists can run successful practices and provide needed care, but only if they speak up through survey input to explain how much that care costs. Here’s how to participate in the process when rheumatology CPT codes come up for review.

Filed under:Billing/Coding Tagged with:AMA Relative Value Update Committee (RUC)Current Procedural Terminology (CPT) codes

Why Mental Health Screening Is Essential for Patients with Psoriatic Disease

Catherine Kolonko  |  October 12, 2023

Research suggests that patients with psoriasis and psoriatic arthritis (PsA) have a greater risk of depression, anxiety and, in some cases, substance abuse and dependence than the general population, yet symptoms often go unrecognized and untreated by medical professionals. Both psoriasis and PsA are associated with depression, with up to 30% of patients in either…

Filed under:ConditionsPsoriatic Arthritis Tagged with:Mental HealthPsA Resource Center

Rheumatologists Turn to Social Media to Educate Patients & Combat Misinformation

Linda Childers  |  October 12, 2023

When Taylor Warmoth, MD, a rheumatologist with Arthritis and Osteoporosis Associates (AOA), Lubbock, Texas, posted her first educational video on TikTok in 2022, she anticipated a moderate response. She was surprised when her medical assistant informed her the next day that her video had received over 5,000 views, 800 comments, and her account had gained…

Filed under:Practice SupportTechnology Tagged with:Social Media

Case Report: Hajdu-Cheney Syndrome

Ibtissam Gad, MD, Firas Askar, MD, Sudhaker Rao, MD, & Ayad Alhatib, MD  |  October 11, 2023

Hajdu-Cheney syndrome (HCS) is a rare connective tissue disease, with fewer than 100 cases reported worldwide.1 Hallmark features include acro-osteolysis (i.e., resorption of the distal phalanges of the hands and feet), osteoporosis, facial dysmorphisms, and craniofacial and dental abnormalities. Patients often have short stature and can have neuroanatomical deformities causing intellectual disabilities. These patients can…

Filed under:ConditionsOsteoarthritis and Bone DisordersOther Rheumatic Conditions Tagged with:acro-osteolysiscase reportHajdu-Cheney syndrome

What’s Holding Back Biomarker Innovation, & How Can We Solve It?

Donald Thomas, MD, FACP, FACR, RhMSUS, & Jason Liebowitz, MD  |  October 11, 2023

Think about it. Most rheumatology labs are stuck in the 1960s. Translational biomarker research looks excellent on paper and in theory. However, many barriers exist from the bench to the bedside. This article highlights this problem for the rheumatology community and proposes practical solutions. Case in Point For an example, let’s examine systemic lupus erythematosus…

Filed under:OpinionSpeak Out Rheum Tagged with:Biomarkersinsurance coveragelaboratory tests

In Memoriam: Remembering Frederick Wolfe, MD

Theodore Pincus, MD, & Kaleb Michaud, PhD  |  October 3, 2023

Rheumatology giant Frederick Wolfe, MD, passed away Sept. 5, 2023, in Wichita, Kan. The rheumatology community mourns his loss. Fred was born July 1, 1936, in New York. He graduated from Queens College, N.Y., in 1958, and was a social worker for several years. He earned his medical degree in 1966 from the State University…

Filed under:OpinionProfiles

Findings from a Clinical Trial of Dazodalibep for Sjögren’s Disease

Michele B. Kaufman, PharmD, BCGP  |  September 26, 2023

St.Clair et al. found that patients with Sjögren’s disease treated with dazodalibep experienced greater improvement in key symptoms of dryness, fatigue and pain than patients who received placebo.

Filed under:Biologics/DMARDsDrug UpdatesEULAR/OtherMeeting ReportsSjögren’s Disease Tagged with:EULAR 2023

Break Barriers: Engaging Diverse Participants in Clinical Trials for Patients with Lupus

Jason Liebowitz, MD, FACR  |  September 14, 2023

Misinformation, fear and not having a trusted partner in the medical sector are just a few of the barriers that prevent patients of color from being adequately represented in research and clinical trials for lupus. Experts and patient advocates addressed how to remove these barriers and more during the 2023 ACR Diversification of Clinical Trials Summit.

Filed under:ConditionsMeeting ReportsSystemic Lupus Erythematosus Tagged with:clinical trialsDiversitypatient education

RheumMadness 2023: The Results Are In

David L. Leverenz, MD, MEd  |  September 11, 2023

RheumMadness is an online tournament in which a bracket of teams, representing key learning concepts in rheumatology, compete against each other in a series of head-to-head matchups, much like basketball teams in the NCAA’s March Madness. The 2023 tournament theme was The All Star Season. Each team represented one all star article competing to be…

Filed under:Career DevelopmentConditionsEducation & TrainingProfessional TopicsResearch RheumRheumatoid ArthritisVasculitis Tagged with:AAV FocusRheumANCA-Associated VasculitisAntibodiescyclophosphamideetanerceptFellowsFellows-in-TrainingGlucocorticoidsonline educationpreclinicalprednisoneRheumatology Research FoundationRheumMadnessrituximabTNF-Alpha inhibitor

Rheumatologists Treat Patients While Ukraine Is at War

Catherine Kolonko  |  September 8, 2023

Rheumatologists living in Ukraine press on with their work of treating patients despite the ongoing war that began with a Russian military invasion.

Filed under:Professional TopicsProfiles Tagged with:Disaster preparationVolunteering

  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 245
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences